Aspen Surgical Products Acquires Stork® Labor and Delivery Products

Aspen Surgical Products, Inc. (“Aspen”), a leader in surgical disposable products, announced the acquisition of Stork® (“Stork”), a division of Briggs Healthcare.
Founded in 1958, the Stork line of products includes high-quality, branded sterile disposable obstetric products, such as the Plastibell® Disposable Circumcision Device, the Amnihook® Amniotic Membrane Perforator, the Double-Grip® Umbilical Cord Clamp, the Umbilical Cord Clamp® Clipper, the U-Bag® Pediatric Urine Collection Bag, and the Ready-Rolled® FootPrinter. The acquisition of Stork strengthens Aspen’s broad portfolio of medical and surgical disposables sold into the acute care market.

“The Stork branded products have been a market leader in the labor and delivery space for over 50 years,” said Jason Krieser, CEO of Aspen. “The line fits very well with our current operational and commercial infrastructure, and we believe it is a sound platform for future growth in the obstetrics and gynecology space.”

“Including Stork, we have completed five acquisitions in the last 18 months,” Jason continued. “This, along with our internal manufacturing investments, commercial enhancements, and new product introductions, has helped us improve and expand our portfolio, providing more value to both our distribution partners and our end-user customers.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”